Publications by authors named "Juliane Halangk"

Claim this Profile
I
Influence of alpha-1 antitrypsin heterozygosity on treatment efficacy of HCV combination therapy.
Karin F Kok, Hanneke van Soest, Antonius E van Herwaarden, Martijn G H van Oijen, Greet J Boland, Juliane Halangk

Eur J Gastroenterol Hepatol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection.
Andreas Mas Marques, Tobias Mueller, Justus Welke, Stefan Taube, Christoph Sarrazin, Juliane Halangk

Infect Genet Evol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of angiotensinogen c.1-44G>A and p.M268T variants as risk factors for fibrosis progression in chronic hepatitis C and liver diseases of various etiologies.
Juliane Halangk, Thomas Berg, Konrad Neumann, Christoph Sarrazin, Holger Hinrichsen

Genet Test Mol Biomarkers· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of epoxide hydrolase Y113H gene variant in pancreatic diseases.
Johann Ockenga, Sebastian Strunck, Cora Post, Hans-Ulrich Schulz, Juliane Halangk

Pancreas· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.
Juliane Halangk, Christoph Sarrazin, Konrad Neumann, Gero Puhl, Tobias Mueller

J Hepatol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of endotoxin receptor CD14 and TLR4 gene variants in chronic liver disease.
Thomas Von Hahn, Juliane Halangk, Heiko Witt, Konrad Neumann, Tobias Müller

Scand J Gastroenterol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver disease.
Felix Stickel, Christoph H Osterreicher, Juliane Halangk, Thomas Berg, Nils Homann

Alcohol Clin Exp Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the transforming growth factor beta1 codon 25 (Arg-->Pro) polymorphism in alcoholic liver disease.
Christoph H Osterreicher, Juliane Halangk, Thomas Berg, Eleonora Patsenker, Nils Homann

Cytokine· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease.
Eckart Schott, Heiko Witt, Maria Pascu, Florian van Boemmel, Viola Weich, Juliane Halangk

Eur J Gastroenterol Hepatol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.
Martin Schaefer, Axel Hinzpeter, Ariane Mohmand, Gesa Janssen, Maurice Pich, Juliane Halangk

Hepatology· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection.
Eckart Schott, Heiko Witt, Konrad Neumann, Stefan Taube, Djin-Ye Oh, Juliane Halangk

J Hepatol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection.
Eckart Schott, Heiko Witt, Holger Hinrichsen, Konrad Neumann, Viola Weich, Juliane Halangk

J Hepatol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer.
Matthias Treiber, Hans-Ulrich Schulz, Olfert Landt, Joost P H Drenth, Carlo Castellani, Juliane Halangk

J Mol Med (Berl)· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
Georg Feldmann, Hans Dieter Nischalke, Jacob Nattermann, Brigitte Banas, Thomas Berg, Juliane Halangk

Clin Cancer Res· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis.
Heiko Witt, Miklós Sahin-Tóth, Olfert Landt, Jian-Min Chen, Thilo Kähne, Walter Halangk, Juliane Halangk

Nat Genet· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection.
Tobias Mueller, Andreas Mas-Marques, Christoph Sarrazin, Manfred Wiese, Juliane Halangk

J Hepatol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein E4 allele is associated with poor treatment response in hepatitis C virus (HCV) genotype 1.
Tobias Mueller, Reinhard Gessner, Christoph Sarrazin, Carola Graf, Juliane Halangk

Hepatology· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis